X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-10-08 | ACET | Adicet Bio, Inc. | Orbimed Advisors LLC | 10% | P - Purchase | $1.00 | +5,000,000 | 7,420,781 | +207% | +$5,000,000 | ||||||
2025-10-30 | ANNX | Annexon, Inc. | Carson William H. | Dir | P - Purchase | $3.17 | +4,115 | 46,175 | +10% | +$13,045 | ||||||
| M | 2025-10-08 | ATYR | Atyr Pharma Inc | Schimmel Paul | Dir | P - Purchase | $0.91 | +1,000,000 | 2,101,056 | +91% | +$911,801 | |||||
| M | 2025-11-03 | AWRE | Aware Inc /Ma/ | Amlani Ajay K | Pres, CEO | P - Purchase | $2.23 | +15,489 | 838,041 | +2% | +$34,608 | |||||
2025-10-10 | BINI | Bollinger Innovations, Inc. | Winvest Investment Fund Management Corp. | 10% | P - Purchase | $0.54 | +27,900 | 50,411 | +124% | +$14,980 | ||||||
| M | 2025-10-31 | CLVT | Clarivate Plc | Cornick Kenneth L. | Dir | P - Purchase | $3.42 | +725,000 | 1,032,711 | +236% | +$2,482,000 | |||||
2025-10-31 | CLVT | Clarivate Plc | Snyder Andrew Miles | Dir | P - Purchase | $3.33 | +1,460,000 | 26,011,599 | +6% | +$4,861,800 | ||||||
2025-10-08 | CPSH | Cps Technologies Corp/De/ | Griffith Charles Kellogg Jr | CFO | P - Purchase | $3.00 | +4,000 | 41,792 | +11% | +$12,000 | ||||||
2025-10-08 | CPSH | Cps Technologies Corp/De/ | Mackey Brian T | Pres, CEO | P - Purchase | $3.00 | +16,500 | 36,500 | +83% | +$49,500 | ||||||
2025-10-08 | CPSH | Cps Technologies Corp/De/ | Cavoli Ivo James | Dir | P - Purchase | $3.00 | +25,000 | 49,185 | +103% | +$75,000 | ||||||
2025-10-08 | CPSH | Cps Technologies Corp/De/ | Hughes Francis J Jr | Dir | P - Purchase | $3.00 | +18,333 | 438,009 | +4% | +$54,999 | ||||||
2025-11-03 | DENN | Denny'S Corp | Jumana Capital Investments LLC | See Footnote 1 | P - Purchase | $4.08 | +250,000 | 4,524,905 | +6% | +$1,020,325 | ||||||
| M | 2025-10-20 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $3.63 | +12,190 | 7,246,612 | 0% | +$44,283 | |||||
| M | 2025-10-27 | FNGR | Fingermotion, Inc. | Leong Yew Poh | Dir | P - Purchase | $1.55 | +10,000 | 190,000 | +6% | +$15,505 | |||||
2025-10-27 | GGT | Gabelli Multimedia Trust Inc. | Gabelli Mario J | Control Person of Adviser | P - Purchase | $4.04 | +31,000 | 2,692,050 | +1% | +$125,138 | ||||||
| M | 2025-11-03 | GMGI | Golden Matrix Group, Inc. | Christensen Richard | CFO | P - Purchase | $1.01 | +25,000 | 120,000 | +26% | +$25,200 | |||||
| M | 2025-11-04 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | Dir, 10% | P - Purchase | $3.94 | +648,000 | 5,745,688 | +13% | +$2,551,480 | |||||
2025-11-04 | JBLU | Jetblue Airways Corp | Boneparth Peter | Dir | P - Purchase | $4.12 | +50,000 | 110,398 | +83% | +$206,000 | ||||||
| M | 2025-10-17 | MMLP | Martin Midstream Partners L.P. | Martin Product Sales LLC | 10% | P - Purchase | $2.63 | +138,100 | 2,706,838 | +5% | +$362,725 | |||||
| DM | 2025-10-07 | MNTR | Mentor Capital, Inc. | Billingsley Chester | CEO, 10% | P - Purchase | $0.98 | +29,379 | 2,996,320 | +1% | +$28,907 | |||||
2025-10-27 | NMRA | Neumora Therapeutics, Inc. | Arch Venture Partners Xii, LLC | 10% | P - Purchase | $2.61 | +1,915,700 | 33,847,838 | +6% | +$4,999,977 | ||||||
2025-10-27 | NMRA | Neumora Therapeutics, Inc. | Arch Venture Partners X, LLC | 10% | P - Purchase | $2.61 | +1,915,700 | 33,847,838 | +6% | +$4,999,977 | ||||||
2025-10-27 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $2.61 | +1,915,700 | 33,895,555 | +6% | +$4,999,977 | ||||||
| D | 2025-11-04 | NTRP | Nexttrip, Inc. | Kaplan Andrew Jay | Dir | P - Purchase | $3.00 | +33,400 | 113,400 | +42% | +$100,200 | |||||
2025-10-22 | NUGN | Livento Group, Inc. | Henriksen Michael Gregory Max | Chief Investment Officer, 10% | P - Purchase | $0.00 | +2,000,000,000 | 2,147,483,647 | +185% | +$4,000,000 | ||||||
2025-10-31 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $1.42 | +150,000 | 248,082,576 | 0% | +$213,435 | ||||||
| M | 2025-10-31 | PRTFT | Tax Free Target Maturity Fund For Puerto Rico Residents, Inc. | Rad Investments LLC | 10% | P - Purchase | $0.82 | +15,170 | 8,240,734 | 0% | +$12,439 | |||||
2025-11-04 | PSTV | Plus Therapeutics, Inc. | Sims Andrew John Hugh Macintyre | CFO | P - Purchase | $0.51 | +20,000 | 68,138 | +42% | +$10,200 | ||||||
| M | 2025-10-23 | QRHC | Quest Resource Holding Corp | Kitt Barry M | 10% | P - Purchase | $1.30 | +199,759 | 2,706,148 | +8% | +$260,593 | |||||
| D | 2025-10-23 | RANI | Rani Therapeutics Holdings, Inc. | Imran Mir A | Dir, 10% | P - Purchase | $0.61 | +2,083,334 | 24,817,526 | +9% | +$1,260,417 | |||||
2025-10-15 | RGP | Resources Connection, Inc. | Duchene Kate W | Pres, CEO | P - Purchase | $4.36 | +23,015 | 590,234 | +4% | +$100,451 | ||||||
2025-11-05 | RLMD | Relmada Therapeutics, Inc. | Kelly Paul Edward | COO | P - Purchase | $2.20 | +90,000 | 502,295 | +22% | +$198,000 | ||||||
2025-11-05 | RLMD | Relmada Therapeutics, Inc. | Traversa Sergio | CEO | P - Purchase | $2.20 | +272,500 | 1,272,500 | +27% | +$599,500 | ||||||
2025-11-05 | RLMD | Relmada Therapeutics, Inc. | Ence Chuck | CAO, COO | P - Purchase | $2.20 | +136,000 | 403,931 | +51% | +$299,200 | ||||||
2025-11-05 | RLMD | Relmada Therapeutics, Inc. | Shenouda Maged | CFO | P - Purchase | $2.20 | +500,000 | 788,335 | +173% | +$1,100,000 | ||||||
| M | 2025-10-17 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $1.59 | +75,423 | 1,939,977 | +4% | +$119,965 | |||||
| M | 2025-10-21 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $1.70 | +23,337 | 3,911,640 | +1% | +$39,702 | |||||
| M | 2025-10-21 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $1.70 | +23,337 | 1,963,314 | +1% | +$39,702 | |||||
2025-10-24 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $1.82 | +6,720 | 3,931,710 | 0% | +$12,211 | ||||||
2025-10-24 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $1.82 | +6,720 | 1,967,889 | 0% | +$12,211 | ||||||
2025-11-04 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $1.64 | +8,935 | 1,973,134 | 0% | +$14,644 | ||||||
2025-11-04 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $1.64 | +8,935 | 3,943,745 | 0% | +$14,644 | ||||||
| M | 2025-10-17 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $1.59 | +75,423 | 3,877,126 | +2% | +$119,965 | |||||
| M | 2025-10-24 | RNTX | Rein Therapeutics, Inc. | Voss Capital, LP | 10% | P - Purchase | $1.38 | +306,050 | 1,322,258 | +30% | +$423,466 | |||||
2025-10-08 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.92 | +30,000 | 16,540,425 | 0% | +$27,699 | ||||||
2025-10-30 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.86 | +15,000 | 16,649,491 | 0% | +$12,915 | ||||||
2025-10-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.93 | +14,204 | 16,554,629 | 0% | +$13,147 | ||||||
2025-10-28 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.92 | +35,000 | 16,634,491 | 0% | +$32,029 | ||||||
2025-10-27 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.94 | +34,506 | 16,599,491 | 0% | +$32,522 | ||||||
| D | 2025-10-24 | RYES | Rise Gold Corp. | Mullin Joseph E III | Pres, CEO | P - Purchase | $0.25 | +80,000 | 701,095 | +13% | +$20,000 | |||||
| D | 2025-10-24 | RYES | Rise Gold Corp. | Oliver Daniel Jr | Dir, 10% | P - Purchase | $0.25 | +1,000,000 | 15,873,844 | +7% | +$250,000 | |||||
| D | 2025-10-24 | RYES | Rise Gold Corp. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $0.25 | +5,600,000 | 23,892,684 | +31% | +$1,400,000 | |||||
| M | 2025-11-05 | SCKT | Socket Mobile, Inc. | Bass Charlie | Dir, 10% | P - Purchase | $1.06 | +10,000 | 1,623,151 | +1% | +$10,596 | |||||
| M | 2025-11-03 | SCKT | Socket Mobile, Inc. | Bass Charlie | Dir, 10% | P - Purchase | $1.01 | +10,000 | 1,613,151 | +1% | +$10,092 | |||||
2025-10-03 | SGRP | Spar Group, Inc. | Linnane William | Pres | P - Purchase | $1.02 | +173,000 | 190,909 | +966% | +$176,460 | ||||||
2025-10-20 | SINT | Sintx Technologies, Inc. | Olson Eric K. | Pres, CEO | P - Purchase | $3.40 | +5,800 | 30,775 | +23% | +$19,720 | ||||||
2025-10-15 | STRO | Sutro Biopharma, Inc. | Chow Gregory K. | CFO | P - Purchase | $0.81 | +19,750 | 19,750 | New | +$15,998 | ||||||
2025-10-15 | STRO | Sutro Biopharma, Inc. | Matsui Connie | Dir | P - Purchase | $0.80 | +50,000 | 50,000 | New | +$39,950 | ||||||
2025-10-15 | STRO | Sutro Biopharma, Inc. | Gerber Hans-Peter | CHIEF SCIENTIFIC OFFICER | P - Purchase | $0.80 | +17,000 | 71,832 | +31% | +$13,607 | ||||||
2025-10-15 | STRO | Sutro Biopharma, Inc. | Chung Jane | CEO | P - Purchase | $0.80 | +12,500 | 122,850 | +11% | +$10,011 | ||||||
2025-10-23 | TTRX | Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | P - Purchase | $4.95 | +5,050 | 5,050 | New | +$24,998 | ||||||
2025-10-23 | TTRX | Turn Therapeutics Inc. | Golden Arthur F | Dir | P - Purchase | $4.95 | +20,202 | 30,202 | +202% | +$100,000 | ||||||
2025-10-23 | TTRX | Turn Therapeutics Inc. | Chesed Abraham | Board Observer | P - Purchase | $4.60 | +14,286 | 1,447,268 | +1% | +$65,716 | ||||||
2025-10-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.62 | +3,703,703 | 26,150,015 | +17% | +$5,999,999 | ||||||
2025-10-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.14 | +1,737,764 | 22,446,312 | +8% | +$1,983,333 | ||||||
| AM | 2025-09-29 | VHAIO | Vocodia Holdings Corp | Taylor Paul Richard | COB, COO, 10% | P - Purchase | $0.00 | +2,147,483,647 | 2,147,483,647 | >999% | +$681,760 | |||||
| D | 2025-10-14 | VNRX | Volitionrx Ltd | Reynolds Cameron John | Pres, CEO | P - Purchase | $0.51 | +110,000 | 3,576,641 | +3% | +$56,100 | |||||
| D | 2025-10-14 | VNRX | Volitionrx Ltd | Still Timothy I | Dir | P - Purchase | $0.51 | +48,076 | 1,535,458 | +3% | +$24,519 | |||||
| D | 2025-10-14 | VNRX | Volitionrx Ltd | Innes Guy Archibald | Dir | P - Purchase | $0.51 | +96,153 | 3,436,981 | +3% | +$49,038 | |||||
2025-10-23 | XFOR | X4 Pharmaceuticals, Inc | Craig Adam R | Exec COB | P - Purchase | $2.90 | +86,206 | 376,087 | +30% | +$249,997 | ||||||
| A | 2025-10-27 | YYAI | Airwa Inc. | Belfiore Michael Anthony | Former 10% Owner | P - Purchase | $2.91 | +6,133 | 70,395 | +10% | +$17,847 | |||||
| M | 2025-10-08 | YYAI | Airwa Inc. | Belfiore Michael Anthony | 10% | P - Purchase | $0.32 | +3,213,095 | 3,213,095 | New | +$1,027,122 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |